These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3225761)
1. Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins. Brewster ME; Estes KS; Loftsson T; Perchalski R; Derendorf H; Mullersman G; Bodor N J Pharm Sci; 1988 Nov; 77(11):981-5. PubMed ID: 3225761 [TBL] [Abstract][Full Text] [Related]
2. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs. Wu WM; Wu J; Bodor N Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189 [TBL] [Abstract][Full Text] [Related]
3. Determination of estredox, a compound with sustained estradiol function, and its impurity profile by HPLC. Patthy M; Seres G; Tóth-Sarudy E; Hazai I; Pallagi I; Simay A; Bodor N Pharmazie; 2008 Mar; 63(3):210-6. PubMed ID: 18444509 [TBL] [Abstract][Full Text] [Related]
4. Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-beta-cyclodextrin. Pop E; Loftsson T; Bodor N Pharm Res; 1991 Aug; 8(8):1044-9. PubMed ID: 1924158 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH) secretory dynamics in animals administered estradiol utilizing a chemical delivery system. Millard WJ; Romano TM; Bodor N; Simpkins JW Pharm Res; 1990 Oct; 7(10):1011-8. PubMed ID: 2281029 [TBL] [Abstract][Full Text] [Related]
6. Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate. Bodor N; Drustrup J; Wu W Pharmazie; 2000 Mar; 55(3):206-9. PubMed ID: 10756542 [TBL] [Abstract][Full Text] [Related]
7. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol. Loftsson T; Bodor N Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460 [TBL] [Abstract][Full Text] [Related]
8. Chronic inhibition of hypothalamic-pituitary-ovarian axis and body weight gain by brain-directed delivery of estradiol-17 beta in female rats. Sarkar DK; Friedman SJ; Yen SS; Frautschy SA Neuroendocrinology; 1989 Aug; 50(2):204-10. PubMed ID: 2674763 [TBL] [Abstract][Full Text] [Related]
9. A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats. Estes KS; Brewster ME; Simpkins JW; Bodor N Life Sci; 1987 Mar; 40(13):1327-34. PubMed ID: 3561153 [TBL] [Abstract][Full Text] [Related]
10. A dihydropyridine conjugate which generates high and sustained levels of the corresponding pyridinium salt in the brain does not exhibit neurotoxicity in cynomolgus monkeys. Brewster ME; Estes KS; Perchalski R; Bodor N Neurosci Lett; 1988 May; 87(3):277-82. PubMed ID: 3380349 [TBL] [Abstract][Full Text] [Related]
11. Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. Anderson WR; Simpkins JW; Brewster ME; Bodor N Life Sci; 1988; 42(16):1493-502. PubMed ID: 3352462 [TBL] [Abstract][Full Text] [Related]
12. Design and in vivo testing of 17 beta-estradiol-HP beta CD sublingual tablets. Fridriksdóttir H; Loftsson T; Gudmundsson JA; Bjarnason GJ; Kjeld M; Thorsteinsson T Pharmazie; 1996 Jan; 51(1):39-42. PubMed ID: 8999433 [TBL] [Abstract][Full Text] [Related]
14. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil. Green AR; Guillory JK J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481 [TBL] [Abstract][Full Text] [Related]
15. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
16. Complexation of steroid hormones with cyclodextrin derivatives: substituent effects of the guest molecule on solubility and stability in aqueous solution. Albers E; Müller BW J Pharm Sci; 1992 Aug; 81(8):756-61. PubMed ID: 1403720 [TBL] [Abstract][Full Text] [Related]
17. The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues. I. Dose-response and time-course evaluation. Rahimy MH; Anderson WR; Brewster ME; Bodor N; Simpkins JW Endocrinology; 1991 Aug; 129(2):717-25. PubMed ID: 1855469 [TBL] [Abstract][Full Text] [Related]
18. Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs. Brewster ME; Hora MS; Simpkins JW; Bodor N Pharm Res; 1991 Jun; 8(6):792-5. PubMed ID: 2062811 [TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin (CD) complexes of cholesterol--their potential use in reducing dietary cholesterol intake. Somogyi G; Posta J; Buris L; Varga M Pharmazie; 2006 Feb; 61(2):154-6. PubMed ID: 16526565 [TBL] [Abstract][Full Text] [Related]
20. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state. Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]